Prediction of Amyloid-β pathology in amnestic mild cognitive impairment with neuropsychological tests

Simple item page
dc.contributor.authorBahar-Fuchs, Alex
dc.contributor.authorVillemagne, Victor
dc.contributor.authorOng, Kevin
dc.contributor.authorChetelat, Gael
dc.contributor.authorLamb, Fiona
dc.contributor.authorReininger, Cornelia B
dc.contributor.authorWoodward, Michael
dc.contributor.authorRowe, Christopher
dc.date.accessioned2015-12-10T21:56:13Z
dc.date.issued2013
dc.date.updated2016-02-24T10:33:33Z
dc.description.abstractAssessment of disease biomarkers, particularly the in vivo assessment of amyloid-β (Aβ) burden with positron emission tomography (PET), is gradually becoming central to the diagnosis of mild cognitive impairment (MCI) due to Alzheimer's disease (AD). Ho
dc.identifier.issn1387-2877
dc.identifier.urihttp://hdl.handle.net/1885/39324
dc.publisherIOS Press
dc.sourceJournal of Alzheimer's Disease
dc.subjectKeywords: amyloid beta protein; florbetaben; adult; aged; Alzheimer disease; amnesia; article; clinical article; cognition; educational status; episodic memory; female; groups by age; hippocampus; human; male; mild cognitive impairment; neuropsychological test; nuc 18F Florbetaben PET; Aging; Alzheimer's disease; amyloid imaging; memory; mild cognitive impairment
dc.titlePrediction of Amyloid-β pathology in amnestic mild cognitive impairment with neuropsychological tests
dc.typeJournal article
local.bibliographicCitation.issue2
local.bibliographicCitation.lastpage462
local.bibliographicCitation.startpage451
local.contributor.affiliationBahar-Fuchs, Alex, College of Medicine, Biology and Environment, ANU
local.contributor.affiliationVillemagne, Victor, Austin Health
local.contributor.affiliationOng, Kevin, Austin Health
local.contributor.affiliationChetelat, Gael, Inserm- EPHE-Universite de Caen/Basse-Normandie
local.contributor.affiliationLamb, Fiona, Austin Health
local.contributor.affiliationReininger, Cornelia B, Bayer Pharma AG
local.contributor.affiliationWoodward, Michael, Austin Health
local.contributor.affiliationRowe, Christopher, Austin Health
local.contributor.authoremailu5076397@anu.edu.au
local.contributor.authoruidBahar-Fuchs, Alex, u5076397
local.description.embargo2037-12-31
local.description.notesImported from ARIES
local.identifier.absfor111714 - Mental Health
local.identifier.absseo920112 - Neurodegenerative Disorders Related to Ageing
local.identifier.ariespublicationu4056230xPUB175
local.identifier.citationvolume33
local.identifier.doi10.3233/JAD-2012-121315
local.identifier.scopusID2-s2.0-84872450217
local.identifier.thomsonID000312598300017
local.identifier.uidSubmittedByu4056230
local.type.statusPublished Version

Downloads

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
01_Bahar-Fuchs_Prediction_of_Amyloid-β_2013.pdf
Size:
303.16 KB
Format:
Adobe Portable Document Format
Download

Collections

ANU Research Publications

DSpace software copyright © 2002-2024 LYRASIS